Placental lead and outcome of pregnancy

Area of Science:

• Environmental Health
• Obstetrics & Gynecology
• Toxicology

Background:

• Prenatal lead exposure poses risks to fetal development, including preterm delivery, low birth weight, and impaired mental development.
• Placental lead concentration is proposed as a biomarker for fetal lead exposure.

Purpose of the Study:

• To investigate the relationship between placental lead levels and intrauterine fetal growth.
• To assess the association of placental lead with adverse pregnancy outcomes, such as preterm delivery.

Main Methods:

• Analysis of placental tissue from 89 pregnancies to determine lead concentrations (ng/g dry tissue).
• Comparison of lead levels between placentas from term pregnancies and those with premature rupture of membranes or preterm labor.
• Evaluation of the correlation between placental lead concentrations and fetal growth parameters (birth weight, circumference, length).

Main Results:

• The study population had low mean placental lead concentrations (113.4 ng/g).
• Higher placental lead levels were observed in cases of premature rupture of membranes and preterm labor compared to term pregnancies.
• Pregnancy outcomes were significantly more abnormal in placentas with lead concentrations above 120 ng/g (40.6%) versus those below (8.8%).
• No general association was found between higher placental lead levels and reduced fetal growth parameters.

Conclusions:

• Placental lead concentration may serve as a biomarker for adverse pregnancy outcomes, particularly preterm delivery.
• Elevated placental lead levels are associated with an increased risk of abnormal pregnancy outcomes, independent of fetal growth parameters.